REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 118 filers reported holding REVANCE THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 1.88 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $36,000 | -16.3% | 2,597 | +17.4% | 0.00% | – |
Q1 2022 | $43,000 | 0.0% | 2,213 | -16.9% | 0.00% | – |
Q4 2021 | $43,000 | -17.3% | 2,662 | +42.0% | 0.00% | – |
Q3 2021 | $52,000 | -7.1% | 1,874 | 0.0% | 0.00% | -100.0% |
Q2 2021 | $56,000 | -15.2% | 1,874 | -21.1% | 0.00% | 0.0% |
Q1 2021 | $66,000 | +34.7% | 2,374 | +36.3% | 0.00% | 0.0% |
Q4 2020 | $49,000 | +11.4% | 1,742 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $44,000 | 0.0% | 1,742 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $44,000 | +1366.7% | 1,742 | +771.0% | 0.00% | – |
Q3 2019 | $3,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q2 2019 | $3,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q1 2019 | $3,000 | -25.0% | 200 | 0.0% | 0.00% | – |
Q4 2018 | $4,000 | -20.0% | 200 | 0.0% | 0.00% | – |
Q3 2018 | $5,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q2 2018 | $5,000 | -16.7% | 200 | 0.0% | 0.00% | – |
Q1 2018 | $6,000 | -14.3% | 200 | 0.0% | 0.00% | – |
Q4 2017 | $7,000 | +16.7% | 200 | 0.0% | 0.00% | – |
Q3 2017 | $6,000 | – | 200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Essex Woodlands Management, Inc. | 3,342,047 | $52,671,000 | 26.22% |
NovaQuest Capital Management, L.L.C. | 1,558,426 | $24,561,000 | 22.85% |
Sio Capital Management, LLC | 254,581 | $4,012,000 | 1.08% |
ArrowMark Colorado Holdings LLC | 3,409,217 | $53,729,000 | 0.51% |
Fosun International Ltd | 472,532 | $7,447,000 | 0.47% |
Rhenman & Partners Asset Management AB | 193,181 | $3,045,000 | 0.36% |
Phoenix Investment Adviser LLC | 4,900 | $77,000 | 0.17% |
HARBOURVEST PARTNERS LLC | 26,565 | $419,000 | 0.15% |
Quinn Opportunity Partners LLC | 56,672 | $893,000 | 0.12% |
MFN Partners Management, LP | 46,000 | $725,000 | 0.12% |